Minimed Group, Inc. MMED
NASDAQ
| 07/31/2026 | 04/24/2026 | 01/23/2026 | 10/24/2025 | 07/25/2025 | |
|---|---|---|---|---|---|
| Revenue | 843.00M | 837.00M | 790.00M | 737.50M | 723.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 843.00M | 837.00M | 790.00M | 737.50M | 723.00M |
| Cost of Revenue | 378.00M | 357.00M | 422.00M | 318.50M | 321.00M |
| Gross Profit | 465.00M | 480.00M | 368.00M | 419.00M | 402.00M |
| SG&A Expenses | 312.00M | 299.00M | 309.00M | 287.50M | 283.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 34.00M | 12.00M | 32.00M | 3.50M | -4.00M |
| Total Operating Expenses | 839.00M | 767.00M | 877.00M | 727.50M | 725.00M |
| Operating Income | 4.00M | 70.00M | -87.00M | 10.00M | -2.00M |
| Income Before Tax | 4.00M | -92.00M | -99.00M | 1.00M | -13.00M |
| Income Tax Expenses | 4.00M | 93.00M | 12.00M | 11.50M | 3.00M |
| Earnings from Continuing Operations | 0.00 | -185.00M | -111.00M | -10.50M | -16.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 0.00 | -8.00M | -4.00M | -3.00M |
| Net Income | 0.00 | -185.00M | -119.00M | -14.50M | -19.00M |
| EBIT | 4.00M | 70.00M | -87.00M | 10.00M | -2.00M |
| EBITDA | 45.00M | 109.00M | -48.00M | 49.00M | 37.00M |
| EPS Basic | -0.69 | -0.69 | -0.47 | -0.68 | -0.08 |
| Normalized Basic EPS | 0.01 | 0.17 | -0.24 | -- | -0.01 |
| EPS Diluted | -0.69 | -0.69 | -0.47 | -0.68 | -0.08 |
| Normalized Diluted EPS | 0.01 | 0.17 | -0.24 | -- | -0.01 |
| Average Basic Shares Outstanding | 281.00M | 268.10M | 252.81M | -- | 252.80M |
| Average Diluted Shares Outstanding | 281.00M | 268.10M | 252.81M | 252.76M | 252.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -123.78% | -- | -- | -- |